HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dermatopathia Pigmentosa Reticularis with Salzmann's nodular degeneration of cornea: A rare association.

AbstractBACKGROUND:
Dermatopathia pigmentosa reticularis (DPR) is a very rare autosomal dominant disorder with the diagnostic triad of generalized reticulate hyperpigmentation, noncicatricial alopecia and onychodystrophy.
OBJECTIVE:
To describe the occurrence of Salzmann's nodular degeneration of cornea with moderate dry eye in a patient with Dermatopathia pigmentosa reticularis.
CASE:
We present an 11 year old young Indian girl with DPR who had Salzmann's nodular degeneration of cornea with moderate dry eye. She was put on symptomatic treatment and counseled regarding the course of disease, familial nature and avoidance of exposure to sun.
CONCLUSION:
In a patient of Salzmann`s nodular degeneration with generalized reticulate hyperpigmentation, noncicatricial alopecia and onychodystrophy the diagnosis of DPR must be kept in mind. A multidisciplinary approach is required for the management of such cases.
AuthorsR Goel, S A Bodh, K Sardana, A Goel
JournalNepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH (Nepal J Ophthalmol) Vol. 7 Issue 1 Pg. 79-81 ( 2015) ISSN: 2072-6805 [Print] Nepal
PMID26695611 (Publication Type: Case Reports, Journal Article)
Copyright© NEPjOPH.
Chemical References
  • Keratolytic Agents
  • Ophthalmic Solutions
  • Tretinoin
  • Carboxymethylcellulose Sodium
Topics
  • Alopecia (complications, genetics)
  • Carboxymethylcellulose Sodium (administration & dosage)
  • Child
  • Chromosomes, Human, Pair 17 (genetics)
  • Corneal Dystrophies, Hereditary (complications, drug therapy, genetics)
  • Dry Eye Syndromes (complications, drug therapy, genetics)
  • Female
  • Humans
  • Hyperpigmentation (complications, genetics)
  • Keratolytic Agents (administration & dosage)
  • Nail Diseases (complications, genetics)
  • Ophthalmic Solutions (administration & dosage)
  • Skin Neoplasms (complications, genetics)
  • Tretinoin (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: